S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2010-03	An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity Hartman, Zachary C.; Wei, Junping; Osada, Takuya; Glass, Oliver; Lei, Gangjun; Yang, Xiao-Yi; Peplinski, Sharon; Kim, Dong-Wan; Xia, Wenle; Spector, Neil; Marks, Jeffrey; Barry, William; Hobeika, Amy; Devi, Gayathri; Amalfitano, Andrea; Morse, Michael A.; Lyerly, H. Kim; Clay, Timothy M. Clinical Cancer Research, Vol.16 No.5, pp.1466-1477	DOI
2016-02	Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis Cha, Soojin; Lee, Jeongeun; Shin, Jong-Yeon; Kim, Ji-Yeon; Sim, Sung Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Se-Hoon; Kim, Jong-Il BMC Cancer, Vol.16, p. 170	view file DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2018-11	Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma Kwon, Hyun Jung; Yang, Jeong Mi; Lee, Jeong-Ok; Lee, Jong Seok; Paik, Jin Ho Journal of Translational Medicine, Vol.16 No.1, p. 320	DOI